Microbot Medical (MBOT) Stock Statistics & Valuation Metrics

Microbot Medical has a market cap or net worth of $135.66M. The enterprise value is $0.00.

Microbot Medical has 67,158,040 shares outstanding. The number of shares has decreased by -2.65% in one year.

Microbot Medical’s return on equity (ROE) is -3.24 and return on invested capital (ROIC) is -313.26%.

The current PE Ratio of Microbot Medical is ―. Microbot Medical’s PEG ratio is 0.05.

In the last 12 months, Microbot Medical had revenue of 0.00 and earned -11.44M in profits. Earnings per share was -0.73.

In the last 12 months, operating cash flow was -10.98M and capital expenditures -42.00K, giving a free cash flow of -11.02M billion.

Microbot Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Microbot Medical upcoming earnings date is ―, ―.

Microbot Medical as a current ratio of 2.37, with Debt / Equity ratio of 1.15%

In the past 12 months, Microbot Medical has paid 0.00 in taxes.

Microbot Medical EV to EBITDA ratio is -1.28, with an EV/FCF ratio of -1.64.

Microbot Medical has $80.16M in cash and marketable securities with $899.00K in debt, giving a net cash position of $79.26M billion.

Gross margin is 5.95%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Microbot Medical is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy